Problem: Every year over 15M in the US and 75M Worldwide have root canals filled with rubber rods (gutta percha) resulting in dead teeth. Prone to infection, bone resorption and brittleness; these tombstones often require several revisions/ tooth. The Holy Grail of Regenerative Endodontic Therapy (RET) is to develop a material that promotes in vivo regeneration of pulp-like tissue with regenerated blood vessels (vPLT).
NangioTx, Inc. is a seed-stage biotechnology company whose flagship product is an injectable drug, V-11, that helps create new blood vessels to regenerate tissue. We’re going after root canal’s first.